Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. 3-deoxy 7-oxo DHEA has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
DHEA is the parent steroid from which 7-oxygenated derivatives are formed by hydroxylation at C7 and subsequent oxidation. Deoxygenation at C3 gives a further modified member of that family. Because the two sit on the same route, taking them together does not add independent actions so much as load the same metabolic branch. The relationship is structural and metabolic, and it has not been characterised in human dosing studies for this specific derivative.
7-oxo DHEA is the member of this family that has actually been studied in humans and appears on supplement labels. The 3-deoxy derivative differs by the absence of the 3-hydroxyl group, which changes both conjugation behaviour and the ability to be reduced back toward androgenic steroids. Stacking the two loads the same enzymatic pathway with two close substrates. Anything claimed for one should not be carried over to the other without its own evidence.
Oxygenated steroid derivatives are poorly water soluble, so dissolution is usually the rate-limiting step for oral absorption. Suspending or dissolving the compound in a medium-chain triglyceride carrier raises the fraction that goes into solution in the upper gut. This is general formulation pharmacology rather than a finding specific to this molecule. It affects exposure, not what the molecule does once absorbed.
Lecithin lowers interfacial tension and helps a poorly soluble powder disperse into mixed micelles rather than sitting as undissolved particles. That is the reason it appears in softgel formulations of lipophilic actives generally. It is a delivery aid with no pharmacological contribution of its own here. The pairing is formulation practice.
Nothing specific on file for 3-deoxy 7-oxo DHEA. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for 3-deoxy 7-oxo DHEA. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.